A syringe marked to 50 units holds 0.5mL
Regulatory mechanisms of RANKL presentation to osteoclast precursors
Increased IGF-1 levels: Co-administration promotes higher systemic IGF-1, improving muscle protein synthesis, recovery, and lipolysis
T.JeneyV
Higher dose, possible metabolic reason to cycle that has nothing to do with desensitization
In some embodiments, administration of a formulation or composition or device described herein, in conjunction with otic surgery, medical device implantation, and/or cell transplantation, reduces or prevents cell damage and/or death (e.g., auris sensory hair cell death and/or damage) associated with otic surgery, medical device implantation, and/or cell transplantation